HIGHLIGHTS   |  February 7, 2020   Patient Decision Aid Leads to Improved Decision-Making About Lung Cancer Screening Delivering the PDA to clients of tobacco quit lines, researchers highlighted the importance of broader dissemination and greater effect of the intervention. Read more   Stuart L. Goldberg, MD, Discusses How Physicians Can Better Communicate Cancer Diagnoses The expert spoke about the best way for physicians to discuss biomarker testing with their patients to ensure that they have an understanding and can make the right decisions for their treatment. Read more   In Case You Missed It   Top-Line Data Reported for Pralsetinib in Patients with RET Fusion-Positive NSCLC Independent centrally reviewed top-line data for pralsetinib in patients with RET fusion-positive non-small cell lung cancer (NSCLC) was announced by Blueprint Medicines, the developer of the agent. Read more